IL6 and diffuse large B-cell lymphoma: Notably, a subset of diffuse large B-cell lymphomas (DLBCLs) can be characterized by a polymorphism in the NF-κB1 gene, with decreased expression of the p50 monomer, and constitutive activation of the NF-κB pathway, associated with higher levels of IL-6 in patients [66].